Stocks of Hims & Hers Health Inc (NYSE:HIMS) traded higher last session on Wall Street, down -0.06% to $30.87.
HIMS stock price is now 10.44% away from the 50-day moving average and 50.44% away from the 200-day moving average. The market capitalization of the company currently stands at $6.74B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $24 to $25, Citigroup Downgraded its rating from Neutral to Sell for Hims & Hers Health Inc (NYSE: HIMS). On January 07, 2025, BTIG Research recently initiated its ‘Buy’ rating on the stock quoting a target price of $35, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, Chi Michael, Chief Commercial Officer sold 17,304 shares of the company’s stock on Jan 24 ’25. The stock was sold for $536,424 at an average price of $31.00. Upon completion of the transaction, the Chief Commercial Officer now directly owns 193,601 shares in the company, valued at $5.98 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 23 ’25, Chief Executive Officer Dudum Andrew sold 27,098 shares of the business’s stock. A total of $815,029 was realized by selling the stock at an average price of $30.08. This leaves the insider owning 27,918 shares of the company worth $0.86 million. A total of 18.77% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $8.51 and a high of $35.02. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82. The fifty day moving average price for HIMS is $27.951 and a two-hundred day moving average price translates $20.52015 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-09-30. The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent. For the current quarter, analysts expect HIMS to generate $469.68M in revenue.
